BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther 2020;11:404. [PMID: 32948252 DOI: 10.1186/s13287-020-01849-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Wu Q, Tam PKH. Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. Int J Mol Sci 2022;23:10023. [PMID: 36077421 DOI: 10.3390/ijms231710023] [Reference Citation Analysis]
2 Shirzad M, Nourigorji M, Sajedi A, Ranjbar M, Rasti F, Sourani Z, Moradi M, Mostafa Mir S, Memar MY. Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine. Int Immunopharmacol 2022;111:109161. [PMID: 35998506 DOI: 10.1016/j.intimp.2022.109161] [Reference Citation Analysis]
3 Li JP, Wu KH, Chao WR, Lee YJ, Yang SF, Chao YH. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19. Int J Mol Sci 2022;23:8196. [PMID: 35897770 DOI: 10.3390/ijms23158196] [Reference Citation Analysis]
4 Gál P, Brábek J, Holub M, Jakubek M, Šedo A, Lacina L, Strnadová K, Dubový P, Hornychová H, Ryška A, Smetana K Jr. Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation. Histochem Cell Biol 2022. [PMID: 35867145 DOI: 10.1007/s00418-022-02140-x] [Reference Citation Analysis]
5 Taurino G, Deshmukh R, Villar VH, Chiu M, Shaw R, Hedley A, Shokry E, Sumpton D, Dander E, D'Amico G, Bussolati O, Tardito S. Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis. Mol Metab 2022;:101532. [PMID: 35752287 DOI: 10.1016/j.molmet.2022.101532] [Reference Citation Analysis]
6 Pirsalehi A, Soleimani M, Hajifathali A, Sadeghi B, Farhadihosseinabadi B, Akhlaghi SS, Roshandel E. Decidual stromal cell therapy for generalized lymphadenopathy as a special clinical manifestation of COVID‐19 infection: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sun W, Yan S, Yang C, Yang J, Wang H, Li C, Zhang L, Zhao L, Zhang J, Cheng M, Li X, Xu D. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice. Immunol Invest 2022;:1-19. [PMID: 35332841 DOI: 10.1080/08820139.2022.2055478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kudinov VA, Artyushev RI, Zurina IM, Zorina ES, Lapshin RD, Snopova LB, Mukhina IV, Saburina IN. Inhaled Placental Mesenchymal Stromal Cell Secretome from Two- and Three-Dimensional Cell Cultures Promotes Survival and Regeneration in Acute Lung Injury Model in Mice. Int J Mol Sci 2022;23:3417. [PMID: 35408778 DOI: 10.3390/ijms23073417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Fathi-Kazerooni M, Fattah-Ghazi S, Darzi M, Makarem J, Nasiri R, Salahshour F, Dehghan-Manshadi SA, Kazemnejad S. Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II. Stem Cell Res Ther 2022;13:96. [PMID: 35255966 DOI: 10.1186/s13287-022-02771-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Saleh M, Fotook Kiaei SZ, Kavianpour M. Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Res Ther 2022;13:71. [PMID: 35168663 DOI: 10.1186/s13287-022-02746-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Niknam Z, Jafari A, Golchin A, Danesh Pouya F, Nemati M, Rezaei-Tavirani M, Rasmi Y. Potential therapeutic options for COVID-19: an update on current evidence. Eur J Med Res 2022;27:6. [PMID: 35027080 DOI: 10.1186/s40001-021-00626-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
12 Hmadcha A, Smani T, Sempere-ortells JM, Zhao RC, Soria B. Mesenchymal Stromal Cells for COVID-19 Critical Care Patients. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_7-1] [Reference Citation Analysis]
13 Sharma Y, Pranshu Rao E, Mohanty S. An insight into the molecular mechanisms of mesenchymal stem cells and their translational approaches to combat COVID-19. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00003-9] [Reference Citation Analysis]
14 Mukherjee A, Das B. Mesenchymal stem cells: Novel avenues in combating COVID-19. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00009-x] [Reference Citation Analysis]
15 Hmadcha A, Smani T, Sempere-ortells JM, Zhao RC, Soria B. Mesenchymal Stromal Cells for COVID-19 Critical Care Patients. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_7] [Reference Citation Analysis]
16 Warrier S, Mohana Sundaram S, Varier L, Balasubramanian A. Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19? Placenta 2021;117:161-8. [PMID: 34915433 DOI: 10.1016/j.placenta.2021.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kumar S, Verma R, Tyagi N, Gangenahalli G, Verma YK. Therapeutics effect of mesenchymal stromal cells in reactive oxygen species-induced damages. Hum Cell 2021. [PMID: 34800267 DOI: 10.1007/s13577-021-00646-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Loke XY, Imran SAM, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int J Mol Sci 2021;22:12421. [PMID: 34830303 DOI: 10.3390/ijms222212421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Niemeyer BF, Benam KH. Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2. Pharmacol Ther 2021;:108027. [PMID: 34718070 DOI: 10.1016/j.pharmthera.2021.108027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yang X, You J, Wei Y, Li H, Gao L, Guo Q, Huang Y, Gong C, Yi C. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm. J Mater Chem B 2021;9:8185-201. [PMID: 34528037 DOI: 10.1039/d1tb01446c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Abousamra S, Belinsky D, Van Arnam J, Allard F, Yee E, Gupta R, Kurc T, Samaras D, Saltz J, Chen C. Multi-Class Cell Detection Using Spatial Context Representation. 2021 IEEE/CVF International Conference on Computer Vision (ICCV) 2021. [DOI: 10.1109/iccv48922.2021.00397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kiaie N, Ghanavati SPM, Miremadi SS, Hadipour A, Aghdam RM. Mesenchymal Stem Cell-Derived Exosomes for COVID-19 Therapy, Preclinical and Clinical Evidence. Int J Stem Cells 2021;14:252-61. [PMID: 34158414 DOI: 10.15283/ijsc20182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Moludi J, Qaisar SA, Alizadeh M, Jafari Vayghan H, Naemi M, Rahimi A, Mousavi R. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case-control study of COVID-19 patients. Br J Nutr 2021;:1-9. [PMID: 34420546 DOI: 10.1017/S0007114521003214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
24 Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv 2021;7:eabg5995. [PMID: 34380619 DOI: 10.1126/sciadv.abg5995] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 Liu Y, Ding Y, Hou Y, Yu T, Nie H, Cui Y. The miR-130a-3p/TGF-βRII Axis Participates in Inhibiting the Differentiation of Fibroblasts Induced by TGF-β1. Front Pharmacol 2021;12:732540. [PMID: 34393805 DOI: 10.3389/fphar.2021.732540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Saleh M, Vaezi AA, Aliannejad R, Sohrabpour AA, Kiaei SZF, Shadnoush M, Siavashi V, Aghaghazvini L, Khoundabi B, Abdoli S, Chahardouli B, Seyhoun I, Alijani N, Verdi J. Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial. Stem Cell Res Ther 2021;12:410. [PMID: 34271988 DOI: 10.1186/s13287-021-02483-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 27.0] [Reference Citation Analysis]
27 [DOI: 10.1109/inhence52833.2021.9537290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sharma S, Jeyaraman M, Muthu S, Anudeep TC, Jeyaraman N, Shringeri AS, Kumar V, Somasundaram R, Jain R, Jha SK. A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19. Ann Natl Acad Med Sci 2021;57:202-13. [DOI: 10.1055/s-0041-1731597] [Reference Citation Analysis]
29 Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Dilogo IH, Aditianingsih D, Sugiarto A, Burhan E, Damayanti T, Sitompul PA, Mariana N, Antarianto RD, Liem IK, Kispa T, Mujadid F, Novialdi N, Luviah E, Kurniawati T, Lubis AMT, Rahmatika D. Umbilical cord mesenchymal stromal cells as critical COVID-19 adjuvant therapy: A randomized controlled trial. Stem Cells Transl Med 2021. [PMID: 34102020 DOI: 10.1002/sctm.21-0046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 42.0] [Reference Citation Analysis]
31 Cai Q, Yin F, Hao L, Jiang W. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19. Stem Cells Dev 2021;30:459-72. [PMID: 33715385 DOI: 10.1089/scd.2020.0198] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Pillalamarri N, Abdullah, Ren G, Khan L, Ullah A, Jonnakuti S, Ullah M. Exploring the utility of extracellular vesicles in ameliorating viral infection-associated inflammation, cytokine storm and tissue damage. Transl Oncol. 2021;14:101095. [PMID: 33887552 DOI: 10.1016/j.tranon.2021.101095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
33 Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther 2021;12:192. [PMID: 33736695 DOI: 10.1186/s13287-021-02265-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
34 Wang X, He Z, Zhao X. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review). Exp Ther Med 2021;21:319. [PMID: 33732292 DOI: 10.3892/etm.2021.9750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
35 Xia J, Arai S, Haider KH. Researches and Applications of Stem Cell Secretome. Stem cells: From Potential to Promise 2021. [DOI: 10.1007/978-981-16-0301-3_7] [Reference Citation Analysis]
36 Ono-Uruga Y, Ikeda Y, Matsubara Y. Platelet production using adipose-derived mesenchymal stem cells: Mechanistic studies and clinical application. J Thromb Haemost 2021;19:342-50. [PMID: 33217130 DOI: 10.1111/jth.15181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]